James R. Goff

VP, Investor Relations at Jaguar Gene Therapy

Jim brings more than 25 years of experience directing investor relations and corporate communications programs in the biotechnology, medical technology and energy services industries.

Formerly of AveXis, InterMune, Protein Design Labs and DePuy/J&J.

Links

Previous companies

Org chart

Manager

Joe Nolan

CEO

Peers

Michael Johannesen

Chief Legal Officer

Tony Mitchell

VP, Controller

Bryan Grice

VP of Engineering

Teams

Leadership Team

3 members

Timeline

VP, Investor Relations
Current role

View in org chart